A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease

NCT01561053 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

347

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

BIOLOGICAL: Albumin 5%
BIOLOGICAL: Albumin 20%
BIOLOGICAL: Immunoglobulin

Sponsor

Instituto Grifols, S.A.

Collaborators

[object Object]